Stan Lapidus is an inventor/entrepreneur. He has founded and led three public companies in diagnostics and molecular tools: Cytyc Corp., EXACT Sciences Corp. and Helicos BioSciences. SynapDx, his current start-up, is developing a breakthrough blood test for earlier autism detection. Stan has developed and patented more than 30 inventions, including the ThinPrep® Pap Smear. He teaches a course at MIT on Critical Reading of the Scientific Literature and also serves on the boards of T2 Biosystems, Fractyl Laboratories and Daktari Diagnostics. He was recently inducted into the College of Fellows of the American Institute of Medical and Biological Engineering.

Theresa Tribble has been with SynapDx since its inception and remains motivated by the goal to transform autism diagnosis via cutting edge science. She currently serves as Vice President Commercial Strategy. Theresa started her career at Putnam Associates, consulting to the pharmaceutical and medical device industries. She graduated from Wellesley College and holds an MBA with Distinction from Harvard Business School. She is a member of the Massachusetts Act Early Taskforce and serves on the board of the New England Autism Speaks Chapter.